Vikas Gulani (University of Michigan, Ann Arbor, MI, USA)
Quantitative and Intelligent MRI for Underserved Populations
2020-11-25
Nicole Seiberlich
(University of Michigan, Ann Arbor, MI, USA)
Accessible MRI - Technological and Economic Challenges
2020-11-25
Najat Salameh and Mathieu Sarracanie (Center for Adaptable MRI Technology, University of Basel, Switzerland)
Bringing MRI to the People. What about the ICU?
2020-11-25
Elmar Merkle (University Hospital Basel, Switzerland)
(Re-)Emerging Fields of Lower-field MRI
2020-11-25
Hersh Chandarana (NYU Langone Health, New York, NY, USA)
Lung MRI of COVID-19 Patients
2020-11-25
Sebastian Bickelhaupt (University Hospital Erlangen, Germany)
Opportunities in Interventional and Diagnostic Imaging by Using High-performance Low-field-strength MRI
2020-11-25
Adrienne Campbell-Washburn (NIH, Nat. Heart, Lung, and Blood Institute, Bethesda, MD, USA)
Radiomics and AI in Cancer - Approaches and Analysis
2020-11-03
Masoom Haider (Sinai Health System & University Health Network, Toronto, Canada)
The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.
The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist there can be no guarantee that other customers will achieve the same results.
Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens organization for further details.
MAGNETOM 7T and 9.4T are ongoing research. All data shown are acquired using non-commercial systems under institutional review board permission. Siemens does not intend to commercialize the systems. MAGNETOM Terra is currently under development and is not for sale in the US and in other countries. Its future availability cannot be ensured.
The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens.
MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.
Welcome to MAGNETOM World
Please note that products or claims shown in that site may not be available in your country.